Literature DB >> 31585469

Difficult-to-Treat Antibiotic-Resistant Gram-Negative Pathogens in the Intensive Care Unit: Epidemiology, Outcomes, and Treatment.

Jeffrey R Strich1,2, Sameer S Kadri1.   

Abstract

Antibiotic resistance among gram-negative pathogens is a world-wide problem that poses a constant threat to patients in the intensive care unit and a therapeutic challenge for the intensivist. Furthermore, the substantial economic burden and increased mortality associated with infections due to highly resistant gram-negative pathogens exacerbate these challenges. Understanding the mechanisms, epidemiology, and risk factors for these infections is paramount to the successful control of outbreaks and for guiding therapy which often entails use of antibiotics with suboptimal efficacy and/or toxicity profiles. In this review we will discuss the global epidemiology, burden, risk factors, and treatment of highly resistant gram-negative infections as they apply to the intensive care population. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31585469     DOI: 10.1055/s-0039-1696662

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  3 in total

1.  Clinical Outcomes, Microbiological Characteristics and Risk Factors for Difficult-to-Treat Resistance to Klebsiella pneumoniae Infection.

Authors:  Liyan Cui; Ning Shen; Ping Yang; Chao Liu; Zhenchao Wu; Jiajia Zheng; Juan Yi; Nan Wu; Zhangli Wu; Ming Lu
Journal:  Infect Drug Resist       Date:  2022-10-17       Impact factor: 4.177

Review 2.  Antimicrobial Treatment Duration in Sepsis and Serious Infections.

Authors:  Lindsay M Busch; Sameer S Kadri
Journal:  J Infect Dis       Date:  2020-07-21       Impact factor: 5.226

3.  Rapid Detection of Imipenem Resistance in Gram-Negative Bacteria Using Tabletop Scanning Electron Microscopy: A Preliminary Evaluation.

Authors:  Gabriel Haddad; Anthony Fontanini; Sara Bellali; Tatsuki Takakura; Yusuke Ominami; Akiko Hisada; Linda Hadjadj; Jean-Marc Rolain; Didier Raoult; Jacques Yaacoub Bou Khalil
Journal:  Front Microbiol       Date:  2021-06-16       Impact factor: 5.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.